alexa Strategies To Optimize And Use Bacterial Cytochromes P450 For Drug Discovery & Development
ISSN: 2161-0444

Medicinal Chemistry
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Medicinal Chemistry & Computer Aided Drug Designing
December 08-10, 2014 DoubleTree by Hilton Hotel San Francisco Airport, USA

Nico P E Vermeulen, H Venkataraman, D P Geerke and J N M Commandeur
ScientificTracks Abstracts: Med Chem
DOI: 10.4172/2161-0444.S1.011
Abstract
Drug discovery and development is a costly and time-consuming process involving many steps, from target discovery up to clinical trials. Because drug metabolites often possess pharmacological or toxicological properties, theymay also play an important role in drug action and adverse drug reactions. It is thus important to investigate the metabolism of drugs and drug candidates and to characterize their pharmacological and toxicological properties.Also for the regulatory MIST guidelines, identification, quantification and characterization of major metabolites is considered important. Such studies require large quantities of pure metabolites, which are sometimes difficult to synthesize by conventional chemical methods. Innovative biocatalytic strategies constitute an alternative for these purposes. Although human Cyt P450s are involved metabolism of many drugs, they are inefficient for the production of large quantities of drug metabolites. Engineered bacterial Cyt P450s, e.g. from Bacillus megaterium (P450s BM3), with high activities and selectivities have better perspectives for large-scale metabolite synthesis. We have developed a ?metabolic production and profiling platform? in which libraries of mutant P450 BM3 enzymes are employed for bio-catalytic purposes. Using random mutagenesis, saturation mutagenesis and (computationally guided) sitedirected mutagenesis strategies, we have been able to generate versatile, highly active and highly selective and scalable P450 BM3 mutants. Thus we have generated with high turnovers, regio- and stereo-selective metabolites of ionones, pharmacologically active metabolites and toxicologically relevant chemically reactive metabolites. The strategies to engineer and optimize Cyt P450 BM3 mutants and their possibilities and limitations in drug discovery, development and safety studies will be illustrated with selected examples.
Biography
Nico P E Vermeulen did a Degree in Chemistry (1975, University of Nijmegen, NL), a PhD in Pharmacology (1980, University of Leiden, NL) and was appointed Professor of Molecular Toxicology in 1985 at VU University Amsterdam. He is Head of Department of Chemistry & Pharmaceutical Sciences. His general research interests are Roles molecular and computational toxicology can play in drug discovery, development and safety assessment. And he got the award like European ISSX Scientific Achievement Award (2006), an Honorary Doctorate (University of Copenhagen, 2011) and is a Life Time Honorary Member of ISSX. His work is taken up in the 2001 and 2014 list of Highly Cited Researchers in ?Pharmacology? i.e. the top 1% world-wide.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

materials[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version